|
TVIS20024133
|
Human Papillomavirus |
HPV16 |
K02718 |
1931 |
- |
hg38 |
chr21 |
45929020 |
45929020 |
q22.3 |
PCBP3 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024134
|
Human Papillomavirus |
HPV16 |
K02718 |
2158 |
- |
hg38 |
chr1 |
209417595 |
209417595 |
q32.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024135
|
Human Papillomavirus |
HPV16 |
K02718 |
7020 |
- |
hg38 |
chr5 |
59631416 |
59631416 |
q12.1 |
PDE4D |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024136
|
Human Papillomavirus |
HPV16 |
K02718 |
5623 |
- |
hg38 |
chr16 |
89393645 |
89393645 |
q24.3 |
ANKRD11, ENSG00000288715 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024137
|
Human Papillomavirus |
HPV16 |
K02718 |
5164 |
- |
hg38 |
chr7 |
48777337 |
48777337 |
p12.3 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024138
|
Human Papillomavirus |
HPV16 |
K02718 |
1583 |
- |
hg38 |
chr4 |
147307584 |
147307584 |
q31.22 |
ENSG00000298313 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024139
|
Human Papillomavirus |
HPV16 |
K02718 |
3789 |
- |
hg38 |
chr13 |
86111580 |
86111580 |
q31.1 |
ENSG00000232252 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024140
|
Human Papillomavirus |
HPV16 |
K02718 |
3442 |
- |
hg38 |
chr13 |
46745490 |
46745490 |
q14.2 |
LRCH1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024141
|
Human Papillomavirus |
HPV18 |
X05015 |
6849 |
- |
hg38 |
chr2 |
51134088 |
51134088 |
p16.3 |
NRXN1-DT, NRXN1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024142
|
Human Papillomavirus |
HPV16 |
K02718 |
5332 |
- |
hg38 |
chr12 |
124423879 |
124423879 |
q24.31 |
ENSG00000309806, NCOR2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |